How does TOBRAMYCIN SULFATE work?

TOBRAMYCIN SULFATE works through the following mechanism: Other agent.

What are the most common side effects of TOBRAMYCIN SULFATE?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for TOBRAMYCIN SULFATE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is TOBRAMYCIN SULFATE the same as Tobramycin?

Tobramycin is a brand name for TOBRAMYCIN SULFATE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

TOBRAMYCIN SULFATE

Q: What is TOBRAMYCIN SULFATE used for?

TOBRAMYCIN SULFATE (brand name Tobramycin) is a Aminoglycoside Antibiotic indicated for INDICATIONS AND USAGE: To reduce the development of drug-resistant bacteria and maintain the effectiveness of Tobramycin Injection, USP and other antibacterial drugs, Tobramycin Injection.

Aminoglycoside Antibiotic

Brand names: Tobramycin

Intramuscular, Intravenous

Mechanism of Action

Other agent

Indications

INDICATIONS AND USAGE: To reduce the development of drug-resistant bacteria and maintain the effectiveness of Tobramycin Injection

USP and other antibacterial drugs

Tobramycin Injection

USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available

they should be considered in selecting or modifying antibacterial therapy. In the absence of such data

E. coli

FDA Warnings

WARNINGS Patients treated with tobramycin injection and other aminoglycosides should be under close clinical observation, because these drugs have an inherent potential for causing ototoxicity and nephrotoxicity
The risk of aminoglycoside-induced hearing loss increases with the degree of exposure to either high peak or high trough serum concentrations
When feasible, it is recommended that serial audiograms be obtained in patients old enough to be tested, particularly high-risk patients
Other factors that may increase patient risk are advanced age and dehydration

Known Side Effects

7 documented side effects by frequency

Shortness of Breath

1-10%

Cough

1-10%

Drug Not Working

1-10%

Condition Worsened

1-10%

Fatigue

0.1-1%

Fever

0.1-1%

General Unwellness

0.1-1%

Community Discussions

No community discussions found for TOBRAMYCIN SULFATE yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → TOBRAMYCIN SULFATE openFDA label JSON → TOBRAMYCIN SULFATE FAERS adverse-event reports → TOBRAMYCIN SULFATE ClinicalTrials.gov → completed Phase 2+ trials of TOBRAMYCIN SULFATE

Compare With

7 available comparisons

Formulations

Dosage Forms

Tablet

Route

Intramuscular, Intravenous